IFNG and autoimmune disease: It is difficult to determine, however, whether other adverse effects observed in patients treated with type I IFNs, such as neuropsychiatric effects or induction or exacerbation of preexisting autoimmune disease would also be observed in patients treated with IFNγ due to the relatively limited clinical application of IFNγ therapy.